Brent crude futures rose 25 cents, or ‌0.4%, ‌to $61.37 a barrel at 0055 GMT, and U.S. West Texas Intermediate crude was at ...

While drugmakers like Dr. Reddy's Laboratories and Aurobindo Pharma are in focus on the back of the observations issued by ...

Google-parent Alphabet is the first overweight-rated stock on JPMorgan's list. The firm's $385 price target implies about ...

President Volodymyr Zelenskiy offered to drop Ukraine's aspirations to join the NATO military alliance as he held five hours ...

At the current price, Hindustan Zinc trades at a financial year 2027 estimated Enterprise Value to Earnings before Interest, ...

Corona Remedies raised ₹655.37 crore through the IPO, which was entirely an offer for sale. Since the issue comprised only an ...

MSCI's broadest index of Asia-Pacific shares outside Japan, opens new tab was down 0.6%, led by a drop of as much as 2.7% in ...

The 10% return on the Nifty is a sharp underperformance compared to global peers such as the KOSPI in South Korea, which is ...

Listing gains, if any, are likely to be limited given the moderate subscription across investor categories, believe analysts.

As per latest reports from the unlisted market, shares of Park Medi World were trading at a premium of ₹7 per share. However, ...

From IOC and Can Fin Homes' dividend announcements to Dr. Lal Pathlabs' bonus issue, these stocks will see their record dates ...

Successful bidders are expected to receive the IPO shares of Nephrocare Health Services in their Demat accounts on Tuesday, ...